1) Assess changes in COVID-19 incidence, prevalence, and proportion of infections that are asymptomatic. 2) Assess adherence to mitigation guidance over time and impact of the pandemic on health and wellbeing. 3) Assess how COVID-19 incidence and prevalence differ by key demographic, socio-economic, health, and behavioral factors.
Bi-weekly survey to document self-reported symptoms, bi-weekly NMT swabs for SARS-CoV-2 RT-PCR testing, monthly venous blood draws for SARS-CoV-2 Serology using Abbott Architect chemiluminescent microparticle immunoassay.
Applied BioSystemsTaqPath COVID-19 Combo Kit Assay by ThermoFisher